Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pulse Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Pulse Biosciences, Inc.’s stock price such as:

• Pulse Biosciences, Inc.’s current stock price and volume
• Why Pulse Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for PLSE from analysts
• PLSE’s stock price momentum as measured by its relative strength

About Pulse Biosciences, Inc. (PLSE)

Before we jump into Pulse Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Want to learn more about Pulse Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Pulse Biosciences, Inc..

Pulse Biosciences, Inc.’s Stock Price as of Market Close

As of June 18, 2026, 4:00 PM, CST, Pulse Biosciences, Inc.’s stock price was $25.600.

Pulse Biosciences, Inc. is up 0.59% from its previous closing price of $25.450.

During the last market session, Pulse Biosciences, Inc.’s stock traded between $25.380 and $26.420. Currently, there are approximately 67.99 million shares outstanding for Pulse Biosciences, Inc..

Pulse Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Pulse Biosciences, Inc. Stock Price History

Pulse Biosciences, Inc.’s (PLSE) price is currently up 2.4% so far this month.

During the month of June, Pulse Biosciences, Inc.’s stock price has reached a high of $28.530 and a low of $23.600.

Over the last year, Pulse Biosciences, Inc. has hit prices as high as $28.530 and as low as $12.560. Year to date, Pulse Biosciences, Inc.’s stock is up 86.45%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Pulse Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 17, 2026, there was 1 analyst who downgraded Pulse Biosciences, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Pulse Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Pulse Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Pulse Biosciences, Inc. (PLSE) by visiting AAII Stock Evaluator.

Relative Price Strength of Pulse Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 17, 2026, Pulse Biosciences, Inc. has a weighted four-quarter relative price strength of 9.44%, which translates to a Momentum Score of 80 and is considered to be Strong.

Want to learn more about how Pulse Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Pulse Biosciences, Inc. Stock Price: Bottom Line

As of June 18, 2026, Pulse Biosciences, Inc.’s stock price is $25.600, which is up 0.59% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Pulse Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.